Fineotex Chemical Limited — PPTs, 22-11-2024: Investor Presentation

**Financial Highlights:** Fineotex Chemical reported a revenue of ₹1,457 million in Q2 FY25, marking a 2.7% quarter-on-quarter increase. The gross profit stood at ₹557 million, with a gross profit margin of 38.2%. EBITDA for the quarter was ₹364 million, translating to an EBITDA margin of 25.0%. The profit after tax (PAT) reached ₹321 million, reflecting a 9.9% increase compared to the previous quarter.

**Strategic Initiatives and Growth Drivers:** The company has successfully expanded into the cleaning and hygiene segment, leveraging its expertise in specialty chemicals. This diversification is anticipated to strengthen revenue streams, especially given the post-pandemic rise in demand for hygiene products.

**Business Developments:** Fineotex has raised ₹3,425.5 million through a preferential allotment and expanded capacity at its Ambernath facility by 40,000 MTPA. The company has also secured partnerships with HealthGuard and Eurodye-CTC, enhancing its product portfolio and market reach.

**Market Position and Competitive Advantage:** With a strong presence in over 70 countries, Fineotex maintains a diversified revenue mix and continues to innovate in sustainable practices. The upcoming product developments and collaborations position the company favorably within the competitive landscape.

**Investor Implications:** Fineotex’s consistent growth in revenues, strategic expansion into high-demand segments, and robust financial metrics suggest a positive outlook for investors. The focus on sustainability and product diversification enhances its potential for long-term value creation.